Drug Shortages

CSEM monitors for shortages and discontinuations of medications that are important to endocrinologists' practice. The major source of this information comes from drugshortages.ca. CSEM actively works with Health Canada and manufacturers to advocate for uninterrupted access to these medications for Canadian patients.

Medications of concern:

• GLP-1 agonists
• injectable glucagon
• testosterone injectable
• propylthiouracil tablets
• hydrocortisone tablets and injectables
• fludrocortisone acetate (Florinef®) tablets
• Baqsimi® nasal glucagon powder
• Hypurin® pork insulins